摘要
Tianjin-based pharmaceutical company Tasly Group is investing $40 million to build a production and training center in Maryland, US, to help prepare for the entry of its Compound Danshen Dripping Pills （CDDP） into the American market, the company announced in Shanghai on June 2nd.
